Emami Ltd

Emami Ltd

₹ 604 -0.61%
22 May - close price
About

Emami is engaged in manufacturing & marketing of personal care & healthcare products with an enviable portfolio of household brand names such as BoroPlus, Navratna, Fair and Handsome, Zandu Balm, Kesh King, Zandu Pancharishta, Mentho Plus Balm and others.(Source : 201903 Annual Report Page No: 193)

Key Points

Leadership
The company is one of India’s leading FMCG Companies engaged in the manufacturing & marketing of personal care & healthcare products. [1]

  • Market Cap 26,332 Cr.
  • Current Price 604
  • High / Low 860 / 467
  • Stock P/E 32.8
  • Book Value 61.7
  • Dividend Yield 1.32 %
  • ROCE 33.9 %
  • ROE 31.2 %
  • Face Value 1.00

Pros

  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 29.9%
  • Company has been maintaining a healthy dividend payout of 52.5%

Cons

  • Stock is trading at 9.78 times its book value
  • The company has delivered a poor sales growth of 7.49% over past five years.
  • Tax rate seems low
  • Working capital days have increased from 49.2 days to 72.2 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
770 773 814 983 836 826 865 996 891 906 891 1,049 963
612 604 621 689 636 636 632 682 682 692 645 715 744
Operating Profit 158 169 193 294 199 190 233 314 209 214 246 334 219
OPM % 21% 22% 24% 30% 24% 23% 27% 32% 24% 24% 28% 32% 23%
25 6 42 7 14 8 11 11 11 10 22 15 21
Interest 2 2 2 2 1 2 2 3 3 2 2 2 3
Depreciation 83 88 48 47 64 46 46 46 48 44 45 46 44
Profit before tax 98 85 186 251 148 150 196 276 169 178 220 301 194
Tax % -262% 14% 3% 7% 4% 9% 8% 6% 13% 16% 4% 7% 16%
354 73 180 233 142 137 180 261 147 151 211 279 162
EPS in Rs 8.07 1.67 4.17 5.38 3.27 3.14 4.09 5.92 3.41 3.50 4.87 6.39 3.72
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
1,700 2,076 2,358 2,488 2,531 2,695 2,655 2,881 3,192 3,406 3,578 3,809
1,255 1,536 1,670 1,729 1,812 1,970 1,970 2,000 2,254 2,550 2,632 2,796
Operating Profit 445 541 688 759 719 725 685 880 938 855 946 1,013
OPM % 26% 26% 29% 31% 28% 27% 26% 31% 29% 25% 26% 27%
53 91 44 31 19 25 46 69 90 69 41 68
Interest 5 5 54 58 34 21 21 13 5 7 10 9
Depreciation 35 34 255 309 311 325 336 367 335 247 186 178
Profit before tax 457 592 423 424 393 403 374 569 688 670 791 894
Tax % 12% 18% 14% 20% 22% 25% 19% 20% -22% 6% 8% 10%
402 485 363 340 306 303 302 455 837 627 724 803
EPS in Rs 8.87 10.70 8.00 7.50 6.77 6.68 6.67 10.23 19.02 14.50 16.58 18.48
Dividend Payout % 39% 33% 44% 47% 52% 60% 60% 78% 42% 55% 48% 54%
Compounded Sales Growth
10 Years: 6%
5 Years: 7%
3 Years: 6%
TTM: 6%
Compounded Profit Growth
10 Years: 4%
5 Years: 22%
3 Years: 0%
TTM: 13%
Stock Price CAGR
10 Years: 2%
5 Years: 24%
3 Years: 13%
1 Year: 13%
Return on Equity
10 Years: 26%
5 Years: 31%
3 Years: 30%
Last Year: 31%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 23 23 23 23 23 45 45 44 44 44 44 44
Reserves 909 1,208 1,589 1,732 1,991 2,031 1,778 1,718 2,032 2,259 2,403 2,651
38 36 671 473 326 110 210 101 282 91 94 90
333 410 409 376 458 633 644 656 692 703 728 749
Total Liabilities 1,302 1,676 2,692 2,603 2,798 2,819 2,678 2,520 3,050 3,096 3,269 3,534
396 453 1,918 1,994 1,802 1,680 1,459 1,132 1,344 1,245 1,114 986
CWIP 12 29 67 22 30 36 8 6 3 6 8 13
Investments 296 501 104 128 314 187 156 255 303 293 442 676
599 693 604 460 652 915 1,055 1,126 1,400 1,551 1,706 1,859
Total Assets 1,302 1,676 2,692 2,603 2,798 2,819 2,678 2,520 3,050 3,096 3,269 3,534

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
428 534 562 730 588 554 531 922 644 749 779 896
-140 -237 -1,313 -306 -276 -26 -231 -224 -234 -122 -210 -340
-301 -215 502 -496 -324 -428 -405 -688 -402 -608 -563 -500
Net Cash Flow -13 82 -249 -72 -12 100 -106 9 8 19 6 56

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 17 18 20 14 22 29 42 29 37 44 50 43
Inventory Days 76 59 68 83 87 88 102 118 121 100 102 94
Days Payable 77 90 112 85 109 115 135 138 138 124 143 133
Cash Conversion Cycle 16 -13 -24 12 1 2 9 10 19 20 9 4
Working Capital Days -6 -13 3 -37 15 9 36 9 31 37 38 72
ROCE % 50% 61% 30% 23% 22% 19% 18% 29% 31% 28% 32% 34%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
54.27% 54.27% 54.27% 54.27% 54.52% 54.84% 54.84% 54.84% 54.84% 54.84% 54.84% 54.84%
11.47% 11.25% 11.14% 11.01% 11.46% 11.90% 12.86% 13.46% 14.02% 14.38% 14.11% 12.11%
26.47% 27.02% 27.02% 26.92% 26.22% 25.21% 23.94% 22.06% 21.61% 21.51% 21.70% 23.68%
7.80% 7.47% 7.58% 7.81% 7.81% 8.05% 8.35% 9.63% 9.53% 9.27% 9.36% 9.38%
No. of Shareholders 89,97185,46090,28597,04389,95579,21682,15191,33497,2581,27,8971,28,7251,29,002

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls